Table 1. . Tumor and demographic characteristics of patients with melanoma.
Variables (n = 644 unless otherwise specified) | n (%) or mean ± SD (range) |
---|---|
Age (years) |
60.94 ± 15.59 (range: 11–96) |
Gender: | |
– Male | 390 (60) |
– Female |
254 (40) |
TNM classification/stage: | |
– T0N0M0 | 92 (14) |
– T1N0M0 | 166 (26) |
– T2N0M0 | 273 (42) |
– T3 (any T, N1+, M0) | 82 (13) |
– T4 (any T, any N, M1+) |
31 (5) |
Current status (n = 576): | |
– Alive | 449 (78) |
– Deceased |
127 (22) |
Cancer status (n = 576): | |
– No evidence of cancer | 473 (73) |
– Evidence of cancer | 102 (16) |
– Unknown |
1 (0.2) |
Histologic subtype: | |
– Malignant melanoma NOS | 527 (82) |
– Melanoma in situ | 89 (14) |
– Desmoplastic | 16 (3) |
– Superficial spreading | 6 (0.9) |
– Spindle cell | 3 (0.5) |
– Malignant melanoma in giant pigmented nevus | 2 (0.3) |
– Nodular |
1 (0.2) |
Site: | |
– Head and neck: | 191 (30) |
• Face/ears | 31 (5) |
• Other and unspecified parts of face | 83 (13) |
• Scalp/neck | 78 (12) |
– Trunk | 159 (25) |
– Upper limb and shoulder | 154 (24) |
– Lower limb and hip | 113 (18) |
– NOS/overlapping |
27 (4) |
Breslow thickness (mm) (n = 490) |
2.02 ± 2.05 (range: 0–9.80) |
Serum albumin (g/dl) (n = 564) |
4.13 ± 0.35 (range: 2.5–5.1) |
Serum total calcium (mg/dl) (n = 644) |
9.46 ± 0.50 (range: 7.20–11.30) |
Serum albumin-corrected calcium (mg/dl) (n = 564) | 9.55 ± 0.44 (range: 8.20–11.70) |
NOS: Not otherwise specified; SD: Standard deviation.